Open original FDA record ↗Recall record
- FDA identifier
- Z-1923-2026
- Company in FDA record
- Remel Europe Ltd.
- FDA classification date
- Apr 22, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.
Source facts
- Action
- Firm began notifying consignees on March 25, 2026 via letters titled "Urgent: Medical Device Recall." Laboratory professionals are advised to review results and destroy any remaining inventory of affected lots. Affected lots should not be used for any clinical laboratory testing. Customers should complete and return the included acknowledgement form for replacement/credit to be processed. Notice should be passed on to all who need to be aware. Firm is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence.
- Initiated
- 2026-03-25
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.
- Recall number
- Z-1923-2026
- Recall status
- Open, Classified
- CDRH record ID
- 219344
- FDA classified
- 2026-04-22
- Recall event number
- 98652